Vaxcyte Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2017
Net Income	-766.63	-463.93	-402.27	-223.49	-100.08	Upgrade
Depreciation & Amortization	24.86	15.85	10.17	9.45	3.46	Upgrade
Loss (Gain) From Sale of Assets	-	-	-	-	0.1	Upgrade
Loss (Gain) From Sale of Investments	-14.43	-38.7	-34.78	-0.95	1.41	Upgrade
Stock-Based Compensation	138.85	84.82	48.76	23.65	10.73	Upgrade
Other Operating Activities	-34.77	4.23	-	8	-	Upgrade
Change in Accounts Payable	19.91	34.58	11.23	2.9	-12.47	Upgrade
Change in Other Net Operating Assets	-23.36	-89.48	70.1	9.84	-24.54	Upgrade
Operating Cash Flow	-655.58	-452.63	-296.79	-170.6	-121.39	Upgrade
Capital Expenditures	-56.97	-119.16	-67.88	-5.84	-6.56	Upgrade
Sale of Property, Plant & Equipment	-	-	-	-	0.03	Upgrade
Investment in Securities	494.33	-1,887	-705.43	80.43	-205.78	Upgrade
Investing Cash Flow	437.35	-2,006	-773.31	74.59	-212.31	Upgrade
Issuance of Common Stock	13.01	2,463	643.69	862.41	17.8	Upgrade
Repurchase of Common Stock	-10.99	-14.29	-3.88	-0.86	-	Upgrade
Financing Cash Flow	2.01	2,449	639.81	861.55	17.8	Upgrade
Foreign Exchange Rate Adjustments	2.44	0.43	-6.69	0.14	-0.44	Upgrade
Net Cash Flow	-213.77	-9.36	-436.97	765.67	-316.34	Upgrade
Free Cash Flow	-712.55	-571.79	-364.67	-176.44	-127.95	Upgrade
Free Cash Flow Per Share	-5.24	-4.69	-3.75	-2.72	-2.46	Upgrade
Cash Interest Paid	-	-	-	-	0.01	Upgrade
Levered Free Cash Flow	-430.85	-403.44	-202.41	-107.53	-88.16	Upgrade
Unlevered Free Cash Flow	-430.85	-403.44	-202.41	-107.52	-88.16	Upgrade
Change in Working Capital	-3.45	-54.9	81.32	12.74	-37.01	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.